Detalhe da pesquisa
1.
Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy.
Cancer
; 130(8): 1270-1280, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38153814
2.
Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study.
Hematol Oncol
; 42(1): e3216, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37772620
3.
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes.
Ann Hematol
; 103(2): 437-442, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38060001
4.
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort.
Am J Hematol
; 99(2): 254-262, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38108611
5.
Liquid biopsy: A promising tool for driving strategies and predicting failures in patients with classic Hodgkin lymphoma.
Cytopathology
; 35(2): 182-187, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37340989
6.
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome.
Cancer
; 129(11): 1704-1713, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36932983
7.
Ultrasonography-guided core-needle biopsy of lymphadenopathies suspected of lymphoma: Analysis on diagnostic efficacy and safety of 1000 front-line biopsies in a multicenter Italian study.
Hematol Oncol
; 41(5): 817-827, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37415412
8.
ENABLE: treatment combination including decitabine and venetoclax in acute myeloid leukemia secondary to myeloproliferative neoplasms.
Future Oncol
; 19(2): 103-111, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36651780
9.
Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease.
Int J Mol Sci
; 24(11)2023 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37298547
10.
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic-phase myelofibrosis.
Cancer
; 128(13): 2449-2454, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35363892
11.
Management of chronic myeloid leukaemia patients treated with ponatinib in a real-life setting: A retrospective analysis from the monitoring registries of the Italian Medicines Agency (AIFA).
Br J Haematol
; 198(6): 965-973, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35904979
12.
Liposomal doxorubicin supercharge-containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single-centre phase II study.
Br J Haematol
; 198(5): 847-860, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35819919
13.
Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study.
Blood
; 135(8): 534-541, 2020 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31877211
14.
Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study.
Haematologica
; 107(10): 2356-2364, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35385922
15.
Bone marrow CD3+ CD56+ regulatory T lymphocytes (TR3 -56 cells) are inversely associated with activation and expansion of bone marrow cytotoxic T cells in IPSS-R very-low/low risk MDS patients.
Eur J Haematol
; 109(4): 398-405, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35775392
16.
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome.
Cancer
; 127(15): 2657-2665, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33794557
17.
Second primary malignancy in myelofibrosis patients treated with ruxolitinib.
Br J Haematol
; 193(2): 356-368, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33222197
18.
Mortality rate in patients with chronic myeloid leukemia in chronic phase treated with frontline second generation tyrosine kinase inhibitors: a retrospective analysis by the monitoring registries of the Italian Medicines Agency (AIFA).
Ann Hematol
; 100(2): 481-485, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33415425
19.
Visual and volumetric parameters by 18F-FDG-PET/CT: a head to head comparison for the prediction of outcome in patients with multiple myeloma.
Ann Hematol
; 99(1): 127-135, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31776725
20.
An 1H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia.
Anticancer Drugs
; 31(1): 67-72, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31633499